ADRENORECEPTOR SENSITIVITY AND MAGNESIUM THERAPY IN PATIENTS WITH CARDIAC ARRHYTHMIAS AND CONNECTIVE TISSUE DYSPLASIA
Abstract
Aim. To assess the adrenergic receptor activity and the effects of Magnerot therapy in patients with cardiac arrhythmias and connective tissue dysplasia (CTD).
material and methods. The study included 18–35-year-old patients with cardiac arrhythmias and CTD. In all participants, sympathoadrenal system activity was evaluated via beta-adrenoreceptor sensitivity. In particular, erythrocyte osmotic resistance was measured in the presence of beta-adrenoblockers (diagnostic kit “AGAT Med”, Moscow). Results. Patients with ectopic cardiac arrhythmias and CTD demonstrated increased erythrocyte hemolysis levels in the presence of beta-adrenoblockers, which suggested adrenoreceptor desensitisation in this clinical group. A four-month Magnerot treatment was associated with a significant reduction in desensitisation of erythrocyte beta-adrenoreceptors (p<0,0001). Conclusion. Magnerot therapy improved the adrenoreceptor sensitivity to adrenoblockers.
About the Authors
G. I. Nechaeva
Omsk State Medical Academy, Omsk
Russian Federation
Russian Federation
Yu. V. Moskvina
Omsk State Medical Academy, Omsk
Russian Federation
Russian Federation
S. S. Bubnova
Omsk State Medical Academy, Omsk
Russian Federation
Russian Federation
References
1. Nechaeva G. I., Jakovlev V. M., Druk I. V. et al. Arrhythmias of heart at not differentiated connective tissue dysplasia. Lechawij vrach 2008; 6:2–7. Russian. (Нечаева Г. И., Яковлев В. М., Друк И. В. и др.) Нарушения ритма сердца при недифференцированной дисплазии соединительной ткани. Лечащий врач 2008; 6: 2–7).
2. Zemcovskij Je. V. Dysplastic syndromes and phenotypes. Dysplastic heart. SPb.: Ol’ga; 2007. Russian. (Земцовский Э. В. Диспластические синдромы и фенотипы. Диспластическое сердце. СПб.: Ольга; 2007).
3. Nechaeva G. I., Viktorova I. A. Connective tissue dysplasia: terminology, diagnostics, tactics of maintaining patients. Omsk: Izd-vo OOO «Tipografija BLANKOM»,2007. Russian. (Нечаева Г. И., Викторова И. А. Дисплазия соединительной ткани: терминология, диагностика, тактика ведения пациентов. Омск: Изд-во ООО «Типография БЛАНКОМ»; 2007).
4. Zemcovskij Je. V., Tihonenko V. M., Reeva S. V. Functional diagnostics of a condition of vegetative nervous system. Spb.: INKART; 2004. Russian. (Земцовский Э. В., Тихоненко В. М., Реева С. В. Функциональная диагностика состояния вегетативной нервной системы. Спб.: ИНКАРТ; 2004).
5. Strjuk R. I., Dlusskaja I. G. Adrenoreaktivity and cardiovascular system. M.: Medicina; 2003. Russian. (Стрюк Р. И., Длусская И. Г. Адренореактивность и сердечно-сосудистая система. М.: Медицина; 2003).
6. Nechaeva G. I., Druk I. V., Tihonova O. V. et al. Therapy by magnesium preparations at primary prolapse of the mitral valve Lechawij vrach 2007; 6: 82–4. Russian. (Нечаева Г. И., Друк И. В., Тихонова О. В. и др.) Терапия препаратами магния при первичном пролапсе митрального клапана. Лечащий врач 2007; 6: 82–4).
7. Gorodeckij V. V. Talibov O. B. Magnesium preparations in medical practice. Small encyclopedia of magnesium. M.: Medpraktika; 2003. Russian. (Городецкий В. В. Талибов О. Б. Препараты магния в медицинской практике. Малая энциклопедия магния. М.: Медпрактика; 2003).
8. Fausto de Silva & Willams PJ. Biological chemisrty of elements. Cambrige; 2003.
9. Torshin IYu, Gromova OA. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science; 2009
10. Gromova O. A. Molecular mechanisms of influence of magnesium at connective tissue dysplasia. Connective tissue dysplasia 2008; 1: 25–34. Russian. (Громова О. А. Молекулярные механизмы воздействия магния на дисплазию соединительной ткани. Дисплазия соединительной ткани 2008; 1: 25–34).
Review
For citations:
Nechaeva G.I., Moskvina Yu.V., Bubnova S.S. ADRENORECEPTOR SENSITIVITY AND MAGNESIUM THERAPY IN PATIENTS WITH CARDIAC ARRHYTHMIAS AND CONNECTIVE TISSUE DYSPLASIA. Russian Journal of Cardiology. 2012;(4):69-73. (In Russ.)
Views:
527
Email this article 